RAPP
Financials
- Market Capitalization 1.94 B
- Employee 84
- Founded 2022
- CEO N/A
- Website www.rapportrx.com
- Headquarter Delaware, United States
- FIGI BBG01FRNQ4P1
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1752 |  MBX MBX Biosciences, Inc. - Common Stock | 60.04 USD | -1.65% | +3.36% | +67.71% | +327.03% | 2.86 B USD | ||
| 1954 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 146.03 USD | +0.88% | +3.30% | +30.28% | +97.74% | 2.09 B USD | ||
| 2058 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.28 USD | -0.35% | -15.65% | +12.89% | -4.80% | 1.83 B USD | ||
| 2140 |  MAZE Maze Therapeutics, Inc. - Common Stock | 29.18 USD | -4.55% | -10.22% | +19.93% | -35.20% | 1.61 B USD |
Frequently asked questions about Rapport Therapeutics, Inc. - Common Stock
What is the Rapport Therapeutics, Inc. - Common Stock stock price today?
The current price of Rapport Therapeutics, Inc. - Common Stock (RAPP) is 40.59. Over the past 24 hours, the stock has changed by -2.78%. Follow the RAPP chart for real-time price dynamics.
What is the stock ticker of Rapport Therapeutics, Inc. - Common Stock?
Rapport Therapeutics, Inc. - Common Stock trades under the ticker RAPP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rapport Therapeutics, Inc. - Common Stock stock going up?
RAPP has changed by +3.65% over the last week, +4.37% over the last month, and +54.98% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Rapport Therapeutics, Inc. - Common Stock net income for the last quarter?
Rapport Therapeutics, Inc. - Common Stock reported net income of -19.86 M for the last quarter. The previous quarter showed -33.76 M, which means net income changed by +41.19%.
How many employees does Rapport Therapeutics, Inc. - Common Stock have?
As of the latest available data, Rapport Therapeutics, Inc. - Common Stock has 84 employees. Workforce size can provide additional context about the company's scale and operations.
What is Rapport Therapeutics, Inc. - Common Stock EBITDA?
Rapport Therapeutics, Inc. - Common Stock EBITDA is -23.99 M, and its EBITDA margin is -119.94%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Rapport Therapeutics, Inc. - Common Stock stock?
You can buy Rapport Therapeutics, Inc. - Common Stock (RAPP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rapport Therapeutics, Inc. - Common Stock stock?
Investing in Rapport Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RAPP chart and related analysis on metatrader.com as part of your research.